Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-25 @ 5:06 AM
NCT ID:
NCT03145727
Eligibility Criteria:
Inclusion Criteria:
* Having breast cancer diagnosed through anatomopathological investigation;
* Indication of neoadjuvant or adjuvant chemotherapy treatment with the combination of anthracycline and cyclophosphamide associated with Ondasetron used as a routine of the Santa Rita Hospital chemotherapy service;
* Present Karnofsky score (KPS) higher than 70 points;
* Being female;
* Be between 18 and 65 years of age and be able to participate in outpatient chemotherapy.
Exclusion Criteria:
* Patients with breast cancer treated with chemotherapeutic regimens other than anthracycline and cyclophosphamide;
* Inability to report nausea and vomiting due to neurological changes, difficulty understanding and / or lack of caregivers that may contribute to the completion of the report;
* Be submitted to radiation therapy concomitant with chemotherapy;
* Presence of gastrointestinal and cerebral metastases;
* Presence of cardiac pacemaker;
* Presence of active skin infection in PC6;
* Nausea and vomiting caused by electrolyte disturbances or intestinal;
* Presence of intra-cranial hypertension.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03145727
Study Brief:
Protocol Section:
NCT03145727